Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1287 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Evotec acquires Kinaxo Biotechnologies

Kinaxo’s acquisition establishes Evotec‘s as an integrated drug discovery and early development partner for pharma and biotechnology companies. Kinaxo’s novel technologies are expected to help Evotec arrive at

AP Pharma updates on APF530 program

APF530 is indicated for the prevention of chemotherapy-induced nausea and vomiting. AP Pharma is in the process of preparing a resubmission responsive to the deficiencies listed in the